Navigation Links
Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
Date:6/19/2009

the design, set-up and conduct of the clinical study, which will run at the University Hospital of Northern Norway in Tromso. No further business commitments have been made at this stage."

The clinical phase I study will document the utility of LTX-315 as an immune stimulator in patients vaccinated with GV1001, a vaccine directed against the catalytic subunit of human telomerase. Telomerase is a universal tumour antigen expressed in 85-90% of cancer tissues.

    Corporate Enquiries:

    Anders Fugelli, PhD, Head of Business Development
    Tel +47-924-81-432

    Michelle Kyunghee Kim, Vice President, Business Development, KAEL-GemVax
    +82-2-540-6221



'/>"/>
SOURCE Lytix Biopharma AS
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lytix Closes USD 10.4 Million Funding Round
2. ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
3. Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
4. Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
5. PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million
6. Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
7. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
8. Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
9. Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
10. Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology
11. DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... WI (PRWEB) April 25, 2015 Join ... April 29th: Analyzing Kinase Inhibitor Residence Times using the ... Analysis of inhibitor residence times is increasingly being incorporated ... target can result in improved efficacy, increased therapeutic window ... be determined using immobilized ligand methods such surface plasmon ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Top student ... other San Diego area universities, including UCSD and SDSU, ... judges from prominent local, national and nonprofit companies for ... the 5th Annual Social Innovation Challenge 2015 . ... unique social venture ideas addressing a diverse range of ...
(Date:4/24/2015)... SD and Tempe, AZ (PRWEB) April 24, 2015 ... Technology and Arizona State University (ASU) have entered into ... joint projects. , A memorandum of agreement signed by ... long distance learning, student success and other services particularly, ... resources. , “We have complementary strengths and a ...
(Date:4/24/2015)... April 24, 2015 Leading Regenerative ... in its allogeneic stem-cell product development program and ... reflect the corporate strategic direction. , “I am ... adipose stem cell development program has been kicked ... cGMP manufacturing facility and hiring of our new ...
Breaking Biology Technology:BellBrook Labs Webinar: Analyzing Kinase Inhibitor Residence Times using the Transcreener® ADP Assay 25th Annual Social Innovation Challenge at University of San Diego - Students Pitch to Live Judging Panel to Take Home $75K 25th Annual Social Innovation Challenge at University of San Diego - Students Pitch to Live Judging Panel to Take Home $75K 3South Dakota Mines, Arizona State University Pave Way for Cooperative Research 2Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma 2
... 27 MichBio, the association for,Michigan,s biosciences industry, ... to its program on day one of its ... Rock Financial ShowPlace Novi, MI. The,event will provide ... bioscience technologies and emerging companies to an audience ...
... FRANCISCO, Aug. 27 Nile Therapeutics,Inc., (Nasdaq: NLTX ... Nile, will present at the NewsMakers in the Biotech ... at the Millennium,Broadway Hotel in New York City. Mr. ... status of Nile,s current clinical development,programs., The presentation ...
... of students with known allergies are urged to put auto-injectable ... epinephrine at the top of the school supplies list, ... by,the National Association of School Nurses (NASN) found that 72% ... or prior use of,epinephrine whose parents have not provided the ...
Cached Biology Technology:Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo 2Nile Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 3Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 4
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition ... Report" report to their offering. This report analyzes ... by the following Segments: Face Biometrics, and Voice Biometrics. The report ... , Japan , Europe , ... & Africa , and Latin America ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ... solutions, today announced that its U.are.U ® ... retailer Goorin Bros . to achieve PCI ... solution secures access to the POS terminal, protecting ... risk of data breaches. With ...
(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... CITY A team of researchers, led by physicians ... ARUP Laboratories, has made a medical breakthrough by discovering ... disease. The disease, pulmonary capillary hemangiomatosis or PCH, ... predominantly in young adults. PCH affects less than one ...
... CORAL GABLES, FL (February 4, 2014) ... builds on existing scholarship exploring the role of robotics ... their widespread deployment everywhere from the home, to hospitals, ... existing legal regimes or requires rethinking of various policy ...
... Cancer Center have discovered a new signaling pathway ... of diseases such as cancer, multiple sclerosis and ... role that activation of interferon-regulatory factor 1 (IRF1), ... of a variety of target genes, plays in ...
Cached Biology News:New hope: Researchers discover genetic mutations that cause rare and deadly lung disease 2New hope: Researchers discover genetic mutations that cause rare and deadly lung disease 3We Robot 2014 April 4th & 5th at University of Miami School of Law 2Newly discovered signaling pathway could impact a variety of autoinflammatory diseases 2
... The Zero Background/Kan Cloning Kit ... kanamycin resistance for selection in ... utilizes positive selection to eliminate ... all of the reagents you ...
GOAT ANTI SLI...
Protein Phosphorylation...
ANTI L-DOPA...
Biology Products: